The present invention relates to biomanufacturing apparatus, for example for cell culturing. In particular, the invention relates to bioreactor apparatus in the form of single instruments, and plural instruments arranged into a biomanufacturing system for optimising the usage of laboratory and cell culturing space for biomanufacturing.
Cell culture, for example the culture of mammalian, bacterial or fungal cells, may be carried out to harvest the living cells for therapeutic purposes and/or to harvest biomolecules, such as proteins or chemicals (e.g. pharmaceuticals) produced by the cells. As used herein, the term “biomolecule” can mean any molecule, such as a protein, peptide, nucleic acid, metabolite, antigen, chemical or biopharmaceutical that is produced by a cell or a virus. Herein, the term biomanufacturing is intended to encompass the culturing or multiplication of cells, and the production of biomolecules. The term bioreactor is intended to encompass a generally enclosed volume capable of being used for biomanufacturing.
The cells are generally grown in large scale (10,000 to 25,000 litre capacity) bioreactors which are sterilisable vessels designed to provide the necessary nutrients and environmental conditions required for cell growth and expansion. Conventional bioreactors have glass or metal growth chambers which can be sterilized and then inoculated with selected cells for subsequent culture and expansion. Media within the growth chambers are often agitated or stirred by the use of mechanical or magnetic impellers to improve aeration, nutrient dispersal and waste removal.
In recent years, there has been a move towards ‘single use’ bioreactors which offer smaller batch sizes, greater production flexibility, ease of use, reduced capital cost investment and reduced risk of cross-contamination. These systems can also improve the efficiency of aeration, feeding and waste removal to increase cell densities and product yields. Examples include WAVE™ bags (GE Healthcare) mounted on rocking platforms for mixing, or stirred-tank single-use vessels such as those available from Xcellerex Inc (GE Healthcare). With the advent of ‘personalised medicine’, autologous cell therapies requiring many small batches of cells to treat patients with unique cell therapies has become important.
Manufacturing facilities, such as tissue culture laboratories, for the production of cells and biomolecules, have traditionally been custom designed and carried out in clean environments to reduce the risk of contamination. Such facilities are costly to run and maintain and also to modify if priorities or work demands change. Work stations for maintaining or harvesting the cells within the bioreactors require a specific ‘footprint’ which occupies a significant floor space in the culture laboratory. As the workstations spend much of their time unattended, while the cells are growing in the bioreactors, the laboratory space is not efficiently or effectively used.
An improvement is proposed in WO 2014122307, wherein the laboratory space required for cell culture is reduced by the provision of customised workstations and storage bays for bioreactors, on which, conventional WAVE type bioreactors and ancillary equipment can be supported. Large supporting frameworks are required for that equipment.
U.S. Pat. No. 6,475,776 is an example of an incubator for cell culture dishes, which has a single incubator housing and multiple shelves, however this type of equipment is not suitable for housing bioreactors.
What is needed is the ability to stack multiple bioreactors one on top of another, closely spaced side by side, in a system that is simple to load, operate and maintain. Ideally such bioreactors should be capable of tradition fed batch manufacturing where cells are cultured typically over 7 to 21 days, as well as perfusion type manufacturing where cells can be cultured for longer periods, but waste products are continually or regularly removed, and biomolecules may be harvested.
A solution to the above mentioned needs has been proposed in unpublished and co-pending patent application GB1518426.0, the contents of which are incorporated herein by reference. Therein, a stackable bioreactor was proposed, which saved on floor space, was capable of providing small batch sizes used in autologous therapies, and did not require clean room conditions. One important aspect of that prior design was a removable rocking platform on which a cell culture bag could be supported during culturing. However, the inventors of the present invention realised that in stacking bioreactors, that platform requires careful design to make it easier to use (removing and loading whilst supporting a bag containing, essentially, liquids in a confined area) and easier to dismantle for cleaning.
The invention provides an arrangement according to claim 1 having preferred features defined by claims dependent on claim 1.
The invention extends to any combination of features disclosed herein, whether or not such a combination is mentioned explicitly herein. Further, where two or more features are mentioned in combination, it is intended that such features may be claimed separately without extending the scope of the invention.
The invention can be put into effect in numerous ways, illustrative embodiments of which are described below with reference to the drawings, wherein:
The invention, together with its objects and the advantages thereof, may be understood better by reference to the following description taken in conjunction with the accompanying drawings, in which like reference numerals identify like elements in the Figures.
Referring to
The chamber 30 has a main chamber 35 and an antechamber 33 leading to the main chamber 35. The main chamber includes a bioreactor tray 40 for example for supporting a cell culture bag—a cell bag herein, supported by a rocking tray support 45 described in more detail below. The rocking mechanism is protected by a cover plate 21. The antechamber 33 includes a panel 34 supporting two peristaltic pumps only the fluid handling heads 48 and 49 of which extend into the antechamber 33, the electrical parts of which are behind the panel 34. The panel also includes connections 43 described in more detail below. The antechamber 33 includes openings 46 defining a route for conduits extending to an external storage area which includes a bag hanging rack 50.
In the embodiment, shown in
Siding of the tray 240 (including the upper and lower frames 270/271) on the heater plate 242 is permitted by means of a tee formation 280 and a complementary tee slot 281, one mounted to the heater plate 242 and one mounted to the lower frame 270, which together allow sliding in the direction of arrow B and the opposing direction. Stops associated with the tee slots prevent complete removal of the lower frame 270 from the heater plate 242, in use.
a/b show further details of tray features. In
Reassembly of the upper frame to the lower frame, and the sliding of the resulting tray assembly, is brought about by reversing the motions described above.
In this way a rocking cell bag support is conceived which is easy to use, allowing convenient insertion and removal of a cell bag, as well as being readily dismantleable for cleaning. For more convenient use a frame position sensor is employed to check alignment of the upper frame 271 with the heater plate 242 in use.
Although embodiments have been described and illustrated, it will be apparent to the skilled addressee that additions, omissions and modifications are possible to those embodiments without departing from the scope of the invention claimed.
Number | Date | Country | Kind |
---|---|---|---|
2632/DEL/2015 | Aug 2015 | IN | national |
1518426 | Oct 2015 | GB | national |
201611015089 | Apr 2016 | IN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2016/070076 | 8/25/2016 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/032830 | 3/2/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4336329 | Hesse | Jun 1982 | A |
8383395 | Hata et al. | Feb 2013 | B2 |
10676705 | Henon et al. | Jun 2020 | B2 |
20060128005 | Hasegawa et al. | Jun 2006 | A1 |
20060191893 | Weinfield | Aug 2006 | A1 |
20090037031 | George et al. | Feb 2009 | A1 |
20110014689 | Gandlur | Jan 2011 | A1 |
20110207209 | Hammons et al. | Aug 2011 | A1 |
20120258441 | Gebauer | Oct 2012 | A1 |
20130157355 | Barrett | Jun 2013 | A1 |
20130251483 | Kobayashi et al. | Sep 2013 | A1 |
20130316446 | Andersson | Nov 2013 | A1 |
20180002650 | Han | Jan 2018 | A1 |
20180250666 | Paul et al. | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
101603006 | Dec 2009 | CN |
102556466 | Jul 2012 | CN |
103361271 | Oct 2013 | CN |
2607474 | Jun 2013 | EP |
H037575 | Jan 1991 | JP |
2013135817 | Sep 2013 | WO |
2015048712 | Apr 2015 | WO |
2017032830 | Mar 2017 | WO |
Entry |
---|
International Search Report and the Written Opinion of the International Searching Authority, or the Declaration from International Appl. No. PCT/EP2016/070076, dated Nov. 4, 2016. |
Great Britain Search Report from GB Appl. No. GB1518426.0, dated Jul. 26, 2016. |
Celltainer Biotech, “Cell-tainer single-use bioreactor for cell cultures—CM2SCEU/CM2SCUS”, celltainer.com, [online], Available from: http://celltainer.com/wp-content/uploads/2015/01/cell-culture.pdf [Accessed Jul. 22, 2016] See particularly System Specifications. |
Japanese Office Action for JP Application No. 2018-510088 dated Jun. 15, 2020 (10 pages with English translation). |
GE Healthcare Life Sciences, “WAVE Bioreactor 2/10 and 20/50 systems,” 2011, Data file 28-9520-58 AB, pp. 1-6. |
Chinese Office Action for CN Application No. 201680062250.5 dated Feb. 5, 2021 (17 page, with English translation). |
Japanese Office Action for JP Application No. 2018-510088 dated Apr. 12, 2021 (11 pages, with English translation). |
Number | Date | Country | |
---|---|---|---|
20180251722 A1 | Sep 2018 | US |